Microbiologic evaluation of efficacy of probiotic for correction intestinal disbiosis

Микробиологическое обоснование эффективности пробиотика в коррекции дисбактериоза кишечника
Nelya Bissenova 1, Aigerim Yergaliyeva 1, Kaiyrgeldy Makhambetov 2, Nurkiya Talgatbekova 2
More Detail
1 National Scientific Medical Research Center, Laboratory of Microbiology, Astana, Kazakhstan
2 Astana Medical University, General medicine Faculty, Astana, Kazakhstan
J CLIN MED KAZ, Volume 2, Issue 40, pp. 36-42. https://doi.org/10.23950/1812-2892-2016-2-36-42
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Purpose of the study. To determine the microbiological efficacy of probiotics in the intestinal dysbiosis correction in patients with gastroenterological diseases.
Methods. A prospective bacteriologic research of intestinal dysbiosis of 47 adult patients (36 women (76.5%), 11 men (23.4%), the average age of 38.0 ± 2.1). The first group consisted of patients with gastroenterological diseases (n = 47). Second group - these same patients after correction with probiotics (n = 23). We conducted qualitative and quantitative analysis of intestinal microbiota both groups.
Results. Intestinal microbiocenosis of patients in both groups was included as the obligatory and facultative microflora. In the first group the contents of bifidobacteria in the amount of 108 CFU/g or more was 65.9%, lactobacilli in an amount of 106 CFU/g or higher at 17.0%, E.coli with normal enzymatic activity in an amount of 107 CFU/g or higher in 55.3% of patients, in the second group these indicators were 78.3%, 56.5% and 73.9%, respectively. From facultative microflora in the first group noted the high content of Candida – 4.2%, lactose-negative E.coli - 6.3% and fungi in 8.5% of patients, in the second group these indicators not detected.
Conclusion. Thus, the intestinal microflora of patients after correction of probiotics, is characterized by a significant increase in the number of obligate microflora: lactobacilli, bifidobacteria, E. coli with normal enzymatic activity and reduced the number of Candida, lactose-negative E.coli and fungi.

CITATION

Bissenova N, Yergaliyeva A, Makhambetov K, Talgatbekova N. Microbiologic evaluation of efficacy of probiotic for correction intestinal disbiosis. Journal of Clinical Medicine of Kazakhstan. 2016;2(40):36-42. https://doi.org/10.23950/1812-2892-2016-2-36-42

REFERENCES

  • Yehuda Ringel, Henry C Lin. Using Probiotics in Gastrointestinal Disorders. Am J Gastroenterol Suppl, 2012, No.1, pp.34–40.
  • Culligan E. et al. Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathogens. 2009, No.1, p.19.
  • Richard N. Fedorak; Karen L. Madsen. Probiotics and Prebiotics in Gastrointestinal Disorders. Curr Opin Gastroenterol. 2004, No.20 (2), pp. 146-155.
  • Aziz Koleilat. Probiotics in Gastrointestinal Disorders. Textbook of Clinical Pediatrics, 2012, No. 1, pp.1887-1890.
  • Snelling AM. Effects of probiotics on the gastrointestinal tract. Curr Opin Infect Dis, 2005, No.18(5), pp.420-426.
  • Peera Hemarajata, James Versalivic. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenteral, 2013, No.6 (1), pp.39-51.
  • Irit Chermesh, Rami Eliakin Probiotocs and the gastrointestinal tract: Where are we in 2005? W J of Gastroenterol, 2006, No.12 (6), pp.853-857.
  • Mary Hickson. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol, 2011, No.4 (3), pp.185–197.
  • Aziz Q, Dore J, Emmanuel A, Guarner F. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil, 2013, No.25, pp.4-15.
  • FAO/WHO (2002) Working group report on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada.
  • Carding S, Verbeke K, Vipond D, Bemard M, Owen L. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis, 2015, No.26, pp.261-291.
  • Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol, 2010, No.7 (9), pp.503–514.
  • Ng SC, Lam EF, Lam TT, Chan Y et al. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J Gastroenterol Hepatol, 2013, No.28 (10), pp.1624-1631.
  • New Advances in the Basic and Clinical Gastroenterology. Edited by Prof. Tomasz Brzozowski; 2012, 546 p.
  • Rijkers GT, Bengmark S, Enck P, Haller D et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr , 2010, No.140(3), pp.671S–676S.
  • Kumar S, Bansal A, Chakrabarti A, Singhi S. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial. Crit Care Med, 2013, No. 41(2), pp.565-572.
  • Chuan SL, Chin JC, Chia CL, Jan M et al. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biomedical J, 2014, No.37 (5), pp.259-268.
  • Chang HC, Sae KC. Alteration of Gut Microbiota and Efficacy of Probiotics in Functional Constipation. J Neurogastroenterol Motil, 2015, No.21 (1), pp.4–7.
  • Orenstein A, Chey DW. Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal Disorders. Am J Gastroenterol Suppl, 2012, No. 1, pp.41–46.
  • Gerritsen J, Smidt H, Rijkers GT. Intestinal microbiota in human health and disease: the impact of probiotics. J Genes & Nutrition, 2011, No.6 (3), pp.209-240.
  • Gomes AC, Bueno AA, Machado de Souza RG, Mota JF. Gut microbiota, probiotics and diabetes. Nutrition J, 2014, No.13, p.60.
  • Boesten RJ, De Vos WM. Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. J Clin Gastroenterol, 2008, No.42 (Suppl 3, Pt 2), pp.163–167.
  • Kleerebezem M, Vaughan EE. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol, 2009, No. 63, pp.269–290.
  • Bakteriologicheskaja diagnostika disbakterioza kishechnika (Microbiological diagnosis of intestinal dysbiosis). Metodicheskie rekomendacii. №10.05.044.03. Almaty, 2003, pp.8-18.
  • Bisenova N.M., Yergaliyeva A.S. Microbial landscape conditionally pathogenic enterobacteria in adult patients with intestinal dysbiosis, J Clin.Med.Kaz. 2012, No.1, pp.39-41
  • Bisenova N.M., Yergaliyeva A.S. Analiz mikrobiocenoza kishechnika vzroslyh pacientov (Gut microbiota analysis of adult patients. J Clin.Med.Kaz. 2015, No.3(37), pp.47-51.
  • I.A. Ljagina, T.K. Korneva, O.V. Golovenko, A.V. Veselov. Harakteristika kishechnoj mikroflory u bol’nyh jazvennym kolitom (Сharacterization of the intestinal microflora in patients with ulcerative colitis). RZhGGK, 2008, T.18, No.2, pp.48-54.
  • Hishtova N.S., Zavgorodnij S.A., Trufanova N.A., Ajtenova M.N. Mikrojekologicheskie narushenija gastrointestial’noj sistemy pri hronicheskih disfunkcijah ZhKT u ambulatornyh bol’nyh g.Majkopa (Micro ecological disorders gastrointestinal tract with chronic dysfunction from outpatients of Maycop). Kubanskij nauchnyj medicinskij vestnik. 2009, No.3, pp.138-141.
  • Simanenkov V. I., Suvorov A. N., Solov’eva O. I. Vozmozhnosti probioticheskoj terapii pri nespecificheskom jazvennom kolite (The possibility of probiotic therapy for ulcerative colitis). Vestnik Sanktpeterburgskogo universiteta, 2009, No.2, pp. 54-60
  • Ivashkin V.T., Denisov N.L. Mestnyj immunitet i mikrobiocenoz pri zabolevanijah kishechnika (Local immunity and microbiocenosis bowel diseases). RZhGGK, 2009, T.19, No.6, pp.11-16.
  • Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008, No. 14(3), pp.166-171.
  • Collado MC, Meriluoto J, Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol, 2007, No.45(4), pp.454-60. 
  • Hishtova N.S., Agirov A.H., Zavgorodnij S.A., Namitokov H.A. Izuchenie mikroflory tolstogo kishechnika u bol’nyh s hronicheskimi disfunkcijami ZhKT i korrigirujushhego dejstvija probiotikov dlja ee normalizacii (Study of the colon microflora in patients with chronic gastrointestinal dysfunction and correcting action of probiotics for its normalization). Novye tehnologii, 2012, No.4, pp.53-57.
  • Solov’eva I.V., Belova I.V., Tochilina A.G., Zhirkov V.A. Mikrobiologicheskie osnovy korrekcii «disbioznoj» mikrobioty cheloveka (Microbiological bases intestinal dysbiosis of human). Medicinskij Al’mana, 2013, No.2 (26), pp.60-66.